AEVEX Corp is a defense technology company delivering next-generation navigation and autonomy, uncrewed systems, and adaptable mission solutions engineered to need, delivered at speed, and built for the modern battlespace. Its solutions are sold to agencies and organizations within the DoW, SOF, IC, and allied international partners. The group offers products and solutions such as CompassCore, CompassVision, CompassEngage, Precision Strike Systems, Unmanned Surface Vessels, Long Endurance Aircraft, Additive Manufacturing, Full Spectrum Airborne ISR, Aircraft Modification and Testing, and Others.
Last trade$13.56
Day change+$0.16 (+1.19%)
Day range$12.93 – $13.81
Volume641,720
Market cap$927M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for AVEX.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for AVEX, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Revenue
$189.7M
$201.79M
Cost of revenue
$135.02M
$154.14M
Gross profit
$54.68M
$47.65M
Selling, general and administrative
$29.31M
$22.47M
Research and development
$7.21M
$5.64M
Total operating expenses
$41.77M
$32.28M
Operating income
$12.9M
$15.37M
Interest expense
-$2.66M
-$3.98M
Income before taxes
$24.96M
$9.15M
Income taxes
$41.72M
$2.45M
Net income
-$16.76M
$6.69M
Net income attributable to common shareholders
-$23.86M
$2.33M
EBITDA
$20M
$15.37M
Basic earnings per share
-$0.40
$0.02
Diluted earnings per share
-$0.40
$0.02
Recent news
Company coverage with links to the original publishers.
A class action lawsuit has been filed against Fractyl Health, Inc. for allegedly making materially false and misleading statements about its Revita product's effectiveness and clinical trial integrity during the Class Period of January 13, 2025 to January 29, 2026. Investors with losses are urged to contact the law firm before the October 20, 2026 lead plaintiff deadline. Similar lawsuits have also been filed against Taboola.com Ltd., AEVEX Corp., and Coastal Financial Corporation.
A class action lawsuit has been filed against AEVEX Corp. alleging that IPO offering documents were materially false and misleading. The complaint claims defendants pre-arranged a plan to waive lock-up restrictions and conduct a secondary public offering shortly after the IPO, allowing the controlling private equity owner to sell $207.9 million in holdings while the company received no proceeds. Investors who purchased AEVEX stock during the IPO or between April 17-June 4, 2026 are encouraged to join the case.
A securities fraud class action lawsuit has been filed against AEVEX Corp. (NYSE: AVEX) for allegedly making material misstatements regarding a pre-arranged secondary public offering shortly after its April 2026 IPO. The company failed to disclose that Madison Dearborn Partners planned to waive lock-up restrictions and sell shares, causing the stock to plummet approximately 23% in early June 2026. Investors have until October 20, 2026, to file for lead plaintiff status.
A class action lawsuit has been filed against AEVEX Corp. alleging that the company and underwriters concealed a pre-arranged plan to prematurely override a 180-day lock-up agreement following its April 2026 IPO. The alleged scheme would have allowed Madison (the majority shareholder) to conduct a secondary public offering worth over $200 million shortly after the IPO. Investors who purchased shares during the IPO or between April 17 and June 4, 2026 have until October 20, 2026 to apply as lead plaintiff.
A class action lawsuit has been filed against AEVEX Corp. alleging that IPO offering documents were materially false and misleading. The complaint claims defendants pre-arranged a plan to waive lock-up restrictions and conduct a secondary public offering shortly after the IPO, allowing the controlling private equity owner to sell $207.9 million in holdings while the company received no proceeds. Investors who purchased AEVEX stock during the IPO or between April 17-June 4, 2026 are encouraged to join the case.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.